GleamWall
中文EN

CELC Celcuity Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1603454 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-57.3%
TTM EPS YoY-28.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-1,192.9%
ROA-42.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets110.2%
Debt / equity—
Current ratio14.62x
Interest coverage-11.94x

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio-7.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$145.00M$104.20M
SG&A expense$27.20M$9.06M
Operating income-$172.19M-$113.27M
Interest expense$17.15M$10.28M
Pretax income-$177.04M-$111.78M
Net income-$177.04M-$111.78M
EBITDA-$172.03M-$113.14M
EPS (basic)-3.79-2.83
EPS (diluted)-3.79-2.83
Weighted avg. shares (diluted)46.76M39.45M
Balance sheet
Cash & equivalents$165.70M$22.52M
Short-term investments$275.79M$212.59M
Current assets$465.66M$244.57M
PP&E, net$499,000$336,000
Total assets$466.56M$245.12M
Current liabilities$44.15M$31.72M
Long-term debt$137.55M$105.09M
Total debt$137.55M$105.09M
Total liabilities$366.00M$129.50M
Shareholders' equity$100.56M$115.62M
Net debt-$28.16M$82.58M
Shares outstanding48.24M37.14M
Cash flow statement
Operating cash flow-$153.28M-$83.47M
Capital expenditure$249,000$250,000
Free cash flow-$153.53M-$83.72M
Investing cash flow-$64.08M-$63.07M
Financing cash flow$360.55M$138.39M
Depreciation & amortization$167,000$130,000
Stock-based compensation$21.38M$6.99M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.